Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
May
11
2020
FDA Revises EUA Criteria for Respirators Manufactured in China Faegre Drinker
May
18
2020
The Daubert Toolbox: Revisiting and Appreciating Joiner, the Middle Child Faegre Drinker
May
27
2020
FDA Issues EUA to Increase Availability of Non-Surgical Gowns and Other Apparel Faegre Drinker
Jun
19
2020
FDA’s Revocation of the Hydroxychloroquine and Chloroquine EUA May Test the Limits of PREP Act Immunity Faegre Drinker
Nov
20
2020
COVID-19 Weekly Newsletter: Vaccine Update, Thanksgiving Guidance Faegre Drinker
Dec
7
2020
FDA Issues Guidance for Applicants Seeking Biosimilar/Interchangeable Approval Faegre Drinker
Sep
22
2012
The Federal Circuit’s Recent “Safe Harbor” Ruling Could Impact Biosimilars Drug Development Faegre Drinker
Nov
8
2012
Patent War Between St. Jude Medical and Volcano Has Mixed Results Faegre Drinker
May
13
2013
The Perils and Promise of 3D Printing: Are DIY Life Sciences in Your Future? Faegre Drinker
Jul
19
2013
House Committee Prepares Sustainable Growth Formula (SGR) Legislation Faegre Drinker
Nov
27
2013
FDA’s Warning Letter to 23andMe: Ethical and Legal Issues Faegre Drinker
Oct
5
2014
Endo Pharmaceuticals, Inc. v. Depomed, Inc., Denying Institution of Inter Partes Review IPR2014-00651 Faegre Drinker
Apr
17
2019
New York City is Blazing the Trail to Ban Marijuana Testing of Job Applicants Faegre Drinker
Apr
30
2015
Galderma and Q-Med AB v. Allergan: Decision on Institution of Inter Partes Review IPR2014-01417 Faegre Drinker
May
8
2015
Purdue Pharma v. Depomed: Denying Request for Rehearing Decision on Institution IPR2014-00379 Faegre Drinker
Apr
10
2020
Natural Cosmetics: Products Without a Clear Definition Faegre Drinker
Apr
24
2020
Preparing for the COVID-19 Immunity Preemption Defense Faegre Drinker
May
14
2020
FDA Gives Guidance on Reporting Medical Device Shortages Faegre Drinker
Jul
13
2020
FDA to Resume Prioritized Food Facility and Other Domestic Inspections Based on New Risk Assessment System Faegre Drinker
Feb
12
2021
Double Whammy: Fifth Circuit Affirms Dismissal of Suit Against Generic and Brand-Name Drug Manufacturers Faegre Drinker
Mar
14
2013
Proposed New Requirements on FDA Acceptance of Data from Clinical Studies for Medical Devices Faegre Drinker
May
28
2014
340B Orphan Drug Rule Invalid Faegre Drinker
Feb
5
2019
FDA Expands Big Data Use with Sentinel System Faegre Drinker
Sep
30
2014
Amneal Pharmaceuticals v. Endo Pharmaceuticals, IPR2014-00360: Denying Request for Rehearing of Denial of Institution Faegre Drinker
Jan
14
2015
Torrent Pharmaceuticals Limited v. Merck Frosst Canada & Co.: Denying Petitioner’s Request for Rehearing of Decision on Institution IPR2014-00559 Faegre Drinker
Jun
18
2015
Coalition for Affordable Drugs v. Celgene Corp: Motion for Leave to File Motion for Sanctions IPR2015-01092, 01096, 01102, 01103 Faegre Drinker
Jul
1
2015
American Simmental Assoc. v. Leachman Cattle of Colorado: Stay of Pending Reissue Application to Avoid Inconsistencies with Post Grant Review PGR2015-00005 Faegre Drinker
Sep
20
2019
Post-BMS, Courts Grapple with the Nexus Between Stream of Commerce Activities and the Plaintiff’s Claim Required for Specific Jurisdiction over Manufacturers in Product Liability Cases Faegre Drinker
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins